Non categorizzato Eli Lilly Alzheimer’s drug fails prevention study Marzo 8, 2023 0 commenti Eli Lilly and Company stated on Wednesday that its older-generation drug solanezumab failed to slow the progression of cognitive decline due to Alzheimer’s disease in patients prior to the onset o… About the author:
Get involved!
Comments